Evidence map›Paper›PMID 25397604›Full record

ArticlePloS one2014

Peripheral CD4+ T cell cytokine responses following human challenge and re-challenge with Campylobacter jejuni.

Kelly A Fimlaid, Janet C Lindow, David R Tribble, Janice Y Bunn, Alexander C Maue, Beth D Kirkpatrick

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Campylobacter in Africa - A specific viewpoint.European journal of microbiology & immunology · 2023
    Review
  2. Review
  3. Article
  4. Review
  5. Innate Lymphoid Cells in Response to Intracellular Pathogens: ProtectionFrontiers in cellular and infection microbiology · 2021
    Review
  6. Article
  7. Article
  8. Human Immunity AgainstImmune network · 2019
    Review
  9. Distribution of Capsular Types ofThe American journal of tropical medicine and hygiene · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kelly A FimlaidDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, 05405, United States of America; University of Vermont College of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont, United States of America.
Janet C LindowUniversity of Vermont College of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont, United States of America.
David R TribbleInfectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Janice Y BunnUniversity of Vermont College of Mathematics, Burlington, Vermont, United States of America.
Alexander C MaueNaval Medical Research Center, Enteric Diseases Department, Silver Spring, Maryland, United States of America.
Beth D KirkpatrickDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, 05405, United States of America; University of Vermont College of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont, United States of America.
University of Vermont · USNaval Medical Research Command · USUniformed Services University of the Health Sciences · US

Funding

WEIGHT MAINTENANCE AND PSYCHOLOGICAL BENEFITS OF EXERCISEM01RR000109 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI DUMAS, JULIE A · 1985 to 2010
$24.3M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MATRAJT, MARIANA L · 2006 to 2011
$14.5M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
FIC NIH HHS D43 TW010540NCRR NIH HHS 5M01RR000109NCRR NIH HHS 5P20RR021905-07NCRR NIH HHS M01 RR000109NCRR NIH HHS P20 RR021905NIGMS NIH HHS 8 P20 GM103496-07NIGMS NIH HHS P20 GM103496
6 · The paper itself

Abstract

Campylobacter jejuni is a leading cause of human gastroenteritis worldwide; however, our understanding of the human immune response to C. jejuni infection is limited. A previous human challenge model has shown that C. jejuni elicits IFNγ production by peripheral blood mononuclear cells, a response associated with protection from clinical disease following re-infection. In this study, we investigate T lymphocyte profiles associated with campylobacteriosis using specimens from a new human challenge model in which C. jejuni-naïve subjects were challenged and re-challenged with C. jejuni CG8421. Multiparameter flow cytometry was used to investigate T lymphocytes as a source of cytokines, including IFNγ, and to identify cytokine patterns associated with either campylobacteriosis or protection from disease. Unexpectedly, all but one subject evaluated re-experienced campylobacteriosis after re-challenge. We show that CD4+ T cells make IFNγ and other pro-inflammatory cytokines in response to infection; however, multifunctional cytokine response patterns were not found. Cytokine production from peripheral CD4+ T cells was not enhanced following re-challenge, which may suggest deletion or tolerance. Evaluation of alternative paradigms or models is needed to better understand the immune components of protection from campylobacteriosis.

Indexed as

Models, ImmunologicalCampylobacter InfectionsCampylobacter jejuniCD4-Positive T-LymphocytesCytokinesFlow CytometryHumansRecurrenceCytokines

Identifiers

PMID25397604
PMCPMC4232357
OpenAlexW2067765784

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.